Nautilai™: The Evolution of Nautilus

SEATTLE – As Curi Bio continues its leadership in the field of synthesizing human cells, systems, and data into platforms that speed the development of next generation medicines, it is excited to announce the renaming of its flagship electrophysiology platform from Nautilus to Nautilai™. This change represents the future direction and the unique capabilities of the platform as Curi Bio increasingly focuses on the integration of artificial intelligence and machine learning capabilities to its growing biosystems portfolio. As the leading turnkey platform for multiwell calcium and voltage mapping of cells and tissues, Nautilai continues to push the boundaries of cellular electrophysiology while generating data at a scale that was once unimaginable. With this change, Nautilai becomes fully integrated with Curi Bio’s cutting-edge, cloud-based AI/ML-powered data analytics to enable unparalleled insights into human cellular interactions and behaviors.

This evolution reflects Curi Bio’s relentless commitment to improvement and innovation to address the evolving needs of the scientific community. Current Nautilai customers will see no changes to existing subscriptions, settings, or user experience. The transition to Nautilai will be seamless, and users can continue to expect the same level of data quality and world-class support from the Curi Bio team. All in-field systems will be ready to go with integration into the Curi Cloud.

To learn more about how the Nautilai platforms can improve the predictive power of your experiments, or about Curi Bio’s other human-relevant preclinical platform technologies, please reach out at contact@curibio.com.